Header Artwork
Header Artwork

LIVE WEBINAR

Regulatory Insights: The Future of MedTech and Pharma Under the New Administration

January 28, 2025

1:00 pm ET

Alpa Patel, Thor Rollins, Anita Michael and Rona LeBlanc-Rivera, PhD

The new presidential administration in the United States could significantly impact MedTech and pharmaceutical regulations for manufacturers and product developers. In this webinar our expert panel of scientists and FDA consultants will explore the potential regulatory changes. The presenters will discuss changes in several key areas, including FDA policy shifts, warning and consent letters, vaccine regulation, artificial intelligence (AI) in healthcare, and the supply chain. They will also share firsthand knowledge of ongoing discussions and emerging trends and help you prepare for changes that will shape the future of the healthcare industry.

Attend this webinar and learn about the following:

  • What regulatory changes could be coming in 2025
  • FDA focal points in the new administration
  • Potential impact to the MedTech and Pharm industries

Learn more about the presenters below.

Alpa Patel, M.S., RM (NRCM)

Alpa Patel, M.S., RM (NRCM)

Director of Lab Operations (Healthcare Reprocessing)

Alpa Patel is a certified microbiologist and has been part of the medical device industry for 20 years specializing in cleaning/disinfection and sterilization of reusable medical devices, endoscopes and validation of tissue disinfection or sterilization processes. Her current role as a Director of Lab Operations (Healthcare Reprocessing) at Nelson Labs involves overseeing test method validations...

Thor Rollins

Thor Rollins

RM (NRCM)
Biocompatibility Expert

Thor Rollins is a certified microbiologist and specializes in the selection and conduct of in vitro and in vivo biocompatibility tests. He actively speaks on biocompatibility related topics through Nelson Labs’ external seminars, webinars, and tradeshows. He presented on biocompatibility at the American College of Toxicology annual meeting in 2013 and has published many articles...

19407

Anita Michael

Executive Principal Consultant, Pharma Compliance, Regulatory Compliance Associates

Anita has over 24 years of global regulatory and quality experience, including 16 years operating globally as a pharmaceutical expert, FDA investigator, and FDA pre-approval manager. She specializes in preparation, remediation, and designing of training for individuals at all levels of an organization.

19408

Rona LeBlanc-Rivera, PhD

Principle Consultant, Regulatory Affairs, Regulatory Compliance Associates

Rona has over 23 years of experience spanning the FDA and the pharmaceutical industry. She served as an FDA reviewer in chemistry, manufacturing, and controls for biologics and generic drug applications, a regulatory affair professional, and as a pharmaceutical industry consultant, including support as primary liaison with FDA.